+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Non-Invasive Liver Monitor Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055072
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Non-Invasive Liver Monitor Market is projected to reach USD 469.28 Million in 2026. It is expected to continue growing at a CAGR of 6.66%, reaching USD 690.25 Million by 2032.

Non-Invasive Liver Monitoring: Executive Overview

Non-invasive liver monitors support assessment of liver structure, stiffness, fat accumulation, and related clinical indicators without requiring tissue biopsy. Their relevance is increasing as clinicians seek repeatable tools for earlier risk identification, treatment monitoring, and longitudinal disease management. Adoption depends on clinical validation, workflow integration, reimbursement, operator training, and patient access.

Clinical Workflows Are Shifting Beyond Biopsy-First Assessment

The landscape is moving toward tiered diagnostic pathways that combine medical history, laboratory results, imaging, and non-invasive measurements. This shift can reduce reliance on invasive procedures for selected patients, while reserving biopsy for cases requiring histological clarification. Interoperability, standardized protocols, and clear interpretation thresholds are becoming more important as monitoring expands across primary care, specialty clinics, and hospital settings.

Artificial Intelligence Strengthens Interpretation and Personalization

Artificial intelligence can enhance image interpretation, automate quality checks, identify patterns across multimodal data, and support risk stratification. Its practical value depends on representative training data, transparent validation, clinician oversight, and integration into existing records and workflows. AI should complement-not replace-clinical judgment, particularly where comorbidities, medication effects, or technically limited examinations may affect results.

Regional Insights Span Diverse Access and Regulatory Environments

North America is characterized by advanced specialty care, established diagnostic infrastructure, and strong interest in earlier detection and longitudinal monitoring. Europe combines sophisticated healthcare systems with varied reimbursement and regulatory pathways across countries. Asia-Pacific includes major clinical-technology hubs alongside substantial differences in access, workforce capacity, and disease burden. Latin America is shaped by uneven diagnostic availability and opportunities to expand decentralized care. The Middle East is investing in modern healthcare infrastructure while emphasizing specialized services and technology-enabled delivery. Africa presents significant unmet diagnostic needs, with deployment priorities centered on affordability, portability, training, and dependable maintenance.

Group-Level Priorities Reflect Different Healthcare and Trade Contexts

ASEAN markets emphasize scalable, portable solutions that can function across metropolitan and distributed care settings. BRICS countries combine large and diverse patient populations with differing regulatory, manufacturing, and healthcare-access conditions. The European Union places strong weight on evidence, safety, data governance, and cross-border health-system compatibility. G7 systems generally prioritize clinical utility, quality assurance, and integration with sophisticated care pathways. GCC countries are strengthening specialized and digitally enabled healthcare capacity. NATO members span varied health systems but share interest in resilient supply chains, interoperable infrastructure, and reliable clinical technologies.

Country-Level Conditions Shape Adoption Pathways

Australia and Canada offer organized healthcare systems with opportunities for specialist-led and geographically distributed monitoring. Brazil, Mexico, India, and South Africa require approaches suited to varied access levels, workforce constraints, and public-private care models. China, Japan, and South Korea have strong technology capabilities and aging-population considerations, while regulatory and procurement requirements remain important. France, Germany, Italy, Spain, and the United Kingdom are influenced by evidence standards, reimbursement processes, and integration into established clinical pathways. The United States combines extensive specialty infrastructure with payer, compliance, and workflow requirements. Russia’s adoption environment is shaped by healthcare-system modernization, procurement conditions, and access to validated technologies.

Prioritize Evidence, Interoperability, and Equitable Deployment

Industry leaders should establish indication-specific clinical evidence, define performance and quality-control standards, and demonstrate how measurements change clinical decisions. Products should support interoperable data exchange, efficient training, remote assistance, and clear reporting for both specialists and general clinicians. Regional strategies should account for reimbursement, procurement, local regulation, and maintenance capacity rather than relying on a single global model. Responsible AI governance, cybersecurity, privacy protection, and post-deployment monitoring should be built into commercialization and service plans.

Research Methodology for the Executive Summary

This executive summary uses a structured market-assessment framework focused on non-invasive technologies for liver monitoring. It organizes findings across clinical workflow change, technology development, artificial intelligence, geography, economic groupings, country conditions, and implementation priorities. Insights are framed qualitatively and are limited to evidence-based themes; no market estimates, shares, forecasts, or company-specific claims are presented. Regional and country interpretation considers healthcare infrastructure, regulatory context, reimbursement, workforce capacity, and deployment feasibility.

A More Connected and Patient-Centered Monitoring Model

Non-invasive liver monitoring is positioned to support earlier assessment and more continuous management when its measurements are clinically validated and embedded in coordinated care. The strongest implementation models will combine dependable devices, standardized protocols, interoperable data, appropriate AI assistance, and equitable access. Progress will ultimately depend on demonstrating meaningful clinical utility across different populations and healthcare environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-Invasive Liver Monitor Market, by Test Types
7.1. Introduction
7.2. Blood-Based Biomarker Tests
7.3. Imaging-Based Tests
8. Non-Invasive Liver Monitor Market, by Technology
8.1. Introduction
8.2. Computed Tomography (CT)-Based Techniques
8.3. Magnetic Resonance Elastography (MRE)
8.4. Near-Infrared Spectroscopy (NIRS)
8.5. Serum Biomarker Panels & Scoring
8.6. Ultrasound Elastography
9. Non-Invasive Liver Monitor Market, by Application
9.1. Introduction
9.2. Disease Staging & Monitoring
9.3. Early Disease Diagnosis
9.4. Post-Surgery Monitoring
10. Non-Invasive Liver Monitor Market, by End-User
10.1. Introduction
10.2. Diagnostic Centers
10.3. Hospitals & Clinics
10.4. Research Institutions
11. Non-Invasive Liver Monitor Market, by Patient Type
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Non-Invasive Liver Monitor Market, by Targeted Diseases
12.1. Introduction
12.2. Cirrhosis
12.3. Fatty Liver Disease
12.4. Hepatitis
12.4.1. Hepatitis B
12.4.2. Hepatitis C
12.5. Liver Fibrosis
13. Non-Invasive Liver Monitor Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Non-Invasive Liver Monitor Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Non-Invasive Liver Monitor Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Alpinion Medical Systems USA Inc.
17.3. Bruker Corporation GmbH
17.4. Canon Medical Systems Corporation
17.5. Chison Medical Imaging Co., Ltd.
17.6. Clarius Mobile Health, Inc.
17.7. Echosens S.A.
17.8. Esaote S.p.A.
17.9. F. Hoffmann-La Roche AG
17.10. Fujifilm Holdings Corporation
17.11. GE HealthCare Technologies Inc.
17.12. Hologic, Inc.
17.13. iLiv Diagnostics Inc.
17.14. Konica Minolta, Inc.
17.15. Koninklijke Philips N.V.
17.16. Mindray Medical International Limited
17.17. Perspectum Diagnostics Ltd.
17.18. Quibim
17.19. Randox Laboratories Ltd.
17.20. Resonance Health Limited
17.21. Resoundant, Inc.
17.22. Samsung Medison Co., Ltd.
17.23. Siemens Healthcare Private Limited
17.24. Supersonic Imagine S.A.
17.25. Wuxi HISKY Medical Technologies Co., Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Non-Invasive Liver Monitor Market, Years Considered for the Study
FIGURE 2. Global Non-Invasive Liver Monitor Market, Research Design
FIGURE 3. Global Non-Invasive Liver Monitor Market, Research Framework
FIGURE 4. Global Non-Invasive Liver Monitor Market, Data Triangulation
FIGURE 5. Global Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Non-Invasive Liver Monitor Market Size, by Test Types, 2025 vs 2032 (%)
FIGURE 7. Global Non-Invasive Liver Monitor Market Size, by Test Types, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Non-Invasive Liver Monitor Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Non-Invasive Liver Monitor Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Non-Invasive Liver Monitor Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Non-Invasive Liver Monitor Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Non-Invasive Liver Monitor Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global Non-Invasive Liver Monitor Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Non-Invasive Liver Monitor Market Size, by Patient Type, 2025 vs 2032 (%)
FIGURE 15. Global Non-Invasive Liver Monitor Market Size, by Patient Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2025 vs 2032 (%)
FIGURE 17. Global Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Non-Invasive Liver Monitor Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Non-Invasive Liver Monitor Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Non-Invasive Liver Monitor Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Non-Invasive Liver Monitor Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Non-Invasive Liver Monitor Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Non-Invasive Liver Monitor Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Non-Invasive Liver Monitor Market Segmentation & Coverage
TABLE 2. Global Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 3. Global Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 4. Global Blood-Based Biomarker Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Blood-Based Biomarker Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Blood-Based Biomarker Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Imaging-Based Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Imaging-Based Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Imaging-Based Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 11. Global Computed Tomography (CT)-Based Techniques Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Computed Tomography (CT)-Based Techniques Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Computed Tomography (CT)-Based Techniques Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Magnetic Resonance Elastography (MRE) Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Magnetic Resonance Elastography (MRE) Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Magnetic Resonance Elastography (MRE) Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Near-Infrared Spectroscopy (NIRS) Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Near-Infrared Spectroscopy (NIRS) Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Near-Infrared Spectroscopy (NIRS) Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Serum Biomarker Panels & Scoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Serum Biomarker Panels & Scoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Serum Biomarker Panels & Scoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Ultrasound Elastography Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Ultrasound Elastography Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Ultrasound Elastography Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 27. Global Disease Staging & Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Disease Staging & Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Disease Staging & Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Early Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Early Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Early Disease Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Post-Surgery Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Post-Surgery Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Post-Surgery Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 37. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 47. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 57. Global Cirrhosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Cirrhosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Cirrhosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Fatty Liver Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Fatty Liver Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Fatty Liver Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Hepatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Hepatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Hepatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Hepatitis B Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Hepatitis B Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Hepatitis B Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Hepatitis C Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Hepatitis C Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Hepatitis C Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Liver Fibrosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Liver Fibrosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Liver Fibrosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Non-Invasive Liver Monitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Non-Invasive Liver Monitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 84. North America Non-Invasive Liver Monitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. North America Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 86. North America Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 87. North America Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. North America Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 89. North America Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 90. North America Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 91. North America Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 92. Latin America Non-Invasive Liver Monitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Latin America Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 94. Latin America Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 95. Latin America Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Latin America Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 97. Latin America Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 98. Latin America Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 99. Latin America Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 100. Europe Non-Invasive Liver Monitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Europe Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 102. Europe Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 103. Europe Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Europe Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 105. Europe Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 106. Europe Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 107. Europe Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 108. Middle East Non-Invasive Liver Monitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Middle East Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 110. Middle East Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. Middle East Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Middle East Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 113. Middle East Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 114. Middle East Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 115. Middle East Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 116. Africa Non-Invasive Liver Monitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Africa Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 118. Africa Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 119. Africa Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Africa Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 121. Africa Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 122. Africa Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 123. Africa Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 124. Global Non-Invasive Liver Monitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. ASEAN Non-Invasive Liver Monitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. ASEAN Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 127. ASEAN Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 128. ASEAN Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. ASEAN Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 130. ASEAN Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 131. ASEAN Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 132. ASEAN Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 133. GCC Non-Invasive Liver Monitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. GCC Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 135. GCC Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. GCC Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. GCC Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 138. GCC Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 139. GCC Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 140. GCC Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 141. European Union Non-Invasive Liver Monitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. European Union Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 143. European Union Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. European Union Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. European Union Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 146. European Union Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 147. European Union Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 148. European Union Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 149. BRICS Non-Invasive Liver Monitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. BRICS Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 151. BRICS Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 152. BRICS Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. BRICS Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 154. BRICS Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 155. BRICS Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 156. BRICS Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 157. G7 Non-Invasive Liver Monitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. G7 Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 159. G7 Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. G7 Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. G7 Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 162. G7 Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 163. G7 Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 164. G7 Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 165. NATO Non-Invasive Liver Monitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. NATO Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 167. NATO Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. NATO Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. NATO Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 170. NATO Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 171. NATO Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 172. NATO Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 173. Global Non-Invasive Liver Monitor Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. United States Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 175. United States Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 176. United States Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. United States Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. United States Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 179. United States Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 180. United States Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 181. United States Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 182. Canada Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 183. Canada Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 184. Canada Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 185. Canada Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Canada Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 187. Canada Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 188. Canada Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 189. Canada Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 190. Mexico Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 191. Mexico Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 192. Mexico Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 193. Mexico Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Mexico Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 195. Mexico Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 196. Mexico Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 197. Mexico Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 198. Brazil Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 199. Brazil Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 200. Brazil Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. Brazil Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Brazil Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 203. Brazil Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 204. Brazil Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 205. Brazil Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 206. United Kingdom Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 207. United Kingdom Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 208. United Kingdom Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. United Kingdom Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. United Kingdom Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 211. United Kingdom Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 212. United Kingdom Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 213. United Kingdom Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 214. Germany Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 215. Germany Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 216. Germany Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. Germany Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Germany Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 219. Germany Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 220. Germany Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 221. Germany Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 222. France Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 223. France Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 224. France Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 225. France Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. France Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 227. France Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 228. France Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 229. France Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 230. Russia Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 231. Russia Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 232. Russia Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 233. Russia Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Russia Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 235. Russia Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 236. Russia Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 237. Russia Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 238. Italy Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 239. Italy Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 240. Italy Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 241. Italy Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. Italy Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 243. Italy Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 244. Italy Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 245. Italy Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 246. Spain Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 247. Spain Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 248. Spain Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. Spain Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Spain Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 251. Spain Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 252. Spain Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 253. Spain Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 254. China Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 255. China Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 256. China Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. China Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. China Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 259. China Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 260. China Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 261. China Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 262. India Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 263. India Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 264. India Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. India Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. India Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 267. India Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 268. India Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 269. India Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 270. Japan Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 271. Japan Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 272. Japan Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 273. Japan Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. Japan Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 275. Japan Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 276. Japan Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 277. Japan Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 278. Australia Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 279. Australia Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 280. Australia Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 281. Australia Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. Australia Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 283. Australia Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 284. Australia Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 285. Australia Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 286. South Korea Non-Invasive Liver Monitor Market Size, 2017-2032 (USD Million)
TABLE 287. South Korea Non-Invasive Liver Monitor Market Size, by Test Types, 2017-2032 (USD Million)
TABLE 288. South Korea Non-Invasive Liver Monitor Market Size, by Technology, 2017-2032 (USD Million)
TABLE 289. South Korea Non-Invasive Liver Monitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. South Korea Non-Invasive Liver Monitor Market Size, by End-User, 2017-2032 (USD Million)
TABLE 291. South Korea Non-Invasive Liver Monitor Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 292. South Korea Non-Invasive Liver Monitor Market Size, by Targeted Diseases, 2017-2032 (USD Million)
TABLE 293. South Korea Non-Invasive Liver Monitor Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 294. Global Non-Invasive Liver Monitor Market Share, by Key Player, 2025
TABLE 295. Global Non-Invasive Liver Monitor Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Alpinion Medical Systems USA Inc.
  • Bruker Corporation GmbH
  • Canon Medical Systems Corporation
  • Chison Medical Imaging Co., Ltd.
  • Clarius Mobile Health, Inc.
  • Echosens S.A.
  • Esaote S.p.A.
  • F. Hoffmann-La Roche AG
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • iLiv Diagnostics Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Mindray Medical International Limited
  • Perspectum Diagnostics Ltd.
  • Quibim
  • Randox Laboratories Ltd.
  • Resonance Health Limited
  • Resoundant, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthcare Private Limited
  • Supersonic Imagine S.A.
  • Wuxi HISKY Medical Technologies Co., Ltd.